Abstract
INTRODUCTION: In the US it is estimated that more than 1.2 million partial or complete limb amputations per year cannot be saved because of excessive ischemia time. The purpose of this study was to determine whether perfusion with a novel fusogenic lipid vesicle (FLV) that delivers magnesium adenosine triphosphate (Mg-ATP) directly into cells could maintain amputated limbs viable after prolonged warm ischemia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
